Northwestern Mutual Wealth Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Other funds holding BPMC
IA
HNB
Northwestern Mutual Wealth Management's BPMC Position: Q3 2025 in Review
Northwestern Mutual Wealth Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 850 shares — an estimated $109K sold.
Northwestern Mutual Wealth Management first reported a position in BPMC in Q1 2019 and held it in 19 quarters. The position peaked at $109K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Northwestern Mutual Wealth Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 850 Blueprint Medicines shares in Q3 2025, an estimated $109K.
- Northwestern Mutual Wealth Management first reported a position in Blueprint Medicines in Q1 2019 and held it in 19 quarters.
- Northwestern Mutual Wealth Management's Blueprint Medicines position peaked at $109K in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.